ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,192, issued on Feb. 3, was assigned to VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).
"CD20 binding single domain antibodies" was invented by Jan Tavernier (Balegem, Belgium), Anje Cauwels (Merelbeke, Belgium) and Jose Van Der Heyden (Munte, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates, in part, to agents that bind CD20 and their use as therapeutic agents. The present application further relates to pharmaceutical compositions comprising the CD20 binding agents and their use in the treatment of various diseases."
The patent was filed on Dec. 21, 2021, under Application No. 17/557,729.
*For ...